论文部分内容阅读
目的:研究药物联动在预防高危妊娠剖宫产后出血症状的临床效果观察。方法:选取我院2013~2015年妇产科收治的60例妊娠期重症肝内胆汁淤积症和双胎妊娠的孕妇作为研究对象,在孕妇知情同意下由临床医师采取等距随机抽样法分为观察组和对照组。对照组采用缩宫素进行临床预防和治疗,观察组采用缩宫素+欣母沛进行临床预防和治疗。结果:两组患者术中和术后出血量、不良反应组间比较差异明显,具有统计学意义(P<0.05)。结论:采用药物联动能够有效的对高危妊娠术后出血症状进行预防和治疗,其效果显著,具有临床应用及推广价值。
Objective: To study the clinical effect of drug linkage in preventing post-cesarean section bleeding in high-risk pregnancy. Methods: Sixty pregnant women with severe intrahepatic cholestasis of pregnancy and twin pregnancies who were admitted to our department from 2013 to 2015 in our hospital were selected as research subjects. The pregnant women were randomly divided into Observation group and control group. Control group using oxytocin for clinical prevention and treatment, observation group using oxytocin Xin Yan Pei for clinical prevention and treatment. Results: There was significant difference between the two groups in intraoperative and postoperative bleeding volume and adverse reaction group, with statistical significance (P <0.05). Conclusion: The drug combination can effectively prevent and treat postoperative bleeding in high-risk pregnancy. The effect is significant and has clinical application and promotion value.